| 000 | 01161nam a2200121Ia 4500 | ||
|---|---|---|---|
| 008 | 220620s9999||||xx |||||||||||||| ||und|| | ||
| 100 | _aPinto, Joana||Carvalho, Márcia||De Pinho, Paula Guedes | ||
| 245 | 0 | _aCancer Metabolomics 2018 | |
| 546 | _aEnglish[eng] | ||
| 650 | _acell transporters||pharmacodynamics||cell growth||in vitro study||metabolomic signatures||endometabolome||lung cancer||metabolomics||chemometric methods||bladder cancer||mTOR||metabolite profiling||metabolic pathways||hepatocellular carcinoma||glutamate||senescence MCF7||breath analysis||bio actives||biomarker||gas chromatography–mass spectrometry (GC–MS)||GC-MS||lung||omics||nutraceuticals||glutaminase||metabolism||acylcarnitines||Erwinaze||Kidrolase||glutathione||targeted metabolomics||apoptosis||SLC1A5||essential amino acids||cancer progression||ASCT2||HR MAS||alanine||analytical platforms||volatile organic compound||glutaminolysis||isotope tracing analysis||asparaginase||vitamin E||breast cancer||prognosis||early diagnosis||tocotrienols||NMR||prostate cancer||in vitro||cancer||MDA-MB-231 | ||
| 856 | _uhttps://mdpi.com/books/pdfview/book/1538 | ||
| 942 | _cEB | ||
| 999 |
_c30285 _d30285 |
||